Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul '25 Jul 28, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	5	481	371	1,452	427	-
Market Cap Growth	-20.98%	29.63%	-74.46%	240.07%	-	-
Enterprise Value	-75	336	186	1,407	433	-
Last Close Price	0.01	0.93	0.94	-	-	-
PS Ratio	-	-	-	36786.24	4913.49	-
PB Ratio	-0.19	14.95	2.06	5.05	8.26	-
P/TBV Ratio	-	15.15	2.06	5.07	8.46	-
EV/Sales Ratio	-	-	-	35653.04	4987.86	-
Debt / Equity Ratio	-0.35	0.30	0.05	0.04	1.91	-3.12
Asset Turnover	-	-	-	0	0.00	-
Quick Ratio	0.44	0.78	2.76	4.78	1.31	0.83
Current Ratio	0.50	0.84	3.03	4.92	1.35	0.84
Return on Equity (ROE)	-	-323.51%	-92.70%	-205.40%	-1120.45%	-
Return on Assets (ROA)	-79.18%	-56.48%	-48.78%	-58.92%	-66.85%	-
Return on Capital (ROIC)	-	-129.16%	-61.77%	-69.52%	-80.20%	-
Earnings Yield	-1601.21%	-70.24%	-60.52%	-23.77%	-39.53%	-
FCF Yield	-6024.25%	-47.05%	-63.74%	-13.43%	-17.95%	-
Buyback Yield / Dilution	-78.08%	-72.97%	-47.30%	-10.91%	-14.48%	-

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.